Armstrong Fluid Technology showcases ways to maximize cooling efficiency, boost reliability, and optimize design ...

Circle Pharma, Inc., a clinical-stage biopharmaceutical company dedicated to discovering and developing cell-permeable ...

Phase 2 Clinical Trial in Patients with Heart Failure with Preserved Ejection Fraction Expected to Begin in Q4 2024 SOUTH SAN ...

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality ...

Step inside a breathtaking Silicon Valley mansion owned by a successful Indian immigrant. Explore luxurious interiors, a ...

Combination of masofaniten plus enzalutamide continues to be well tolerated with durable reductions in PSA in patients with ...

The 100% recyclable paper packaging design replaces the non-biodegradable expanded polyethylene ... Featuring a palm-sized chassis, the SSF computer can also be embedded in existing industrial ...

Press Release Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing cell-permeable macrocycles as a new class of therapies, today announced the successful ...

Phase 2 Clinical Trial in Patients with Heart Failure with Preserved Ejection Fraction Expected to Begin in Q4 2024 SOUTH SAN ...

Trishula Therapeutics, Inc., a clinical stage, privately held biotechnology company, today reported final results from a Phase 1 trial of TTX-030, a potential first-in-class, anti-CD39 antibody, in ...

Abdera Therapeutics Inc., a biopharmaceutical company leveraging its advanced antibody engineering ROVEr platform to design and develop tunable, precision radiopharmaceuticals for cancer, announced ...

Apple® today announced iPhone® 16 and iPhone 16 Plus, built for Apple Intelligencetm, the easy-to-use personal intelligence system that understands personal context to deliver intelligence that is ...